The $2.3B impairment and 40%+ cost overrun on Jansen Stage 2 are material negatives for BHP's potash growth thesis, though the long-life, low-cost nature of the asset and maintained 65%+ EBITDA margins provide some offset. Monitor BHP's FY2026 annual results (30 June 2026) for the final carrying value assessment and any further guidance on Stage 1 ramp. The impairment is non-cash but signals reduced market participant valuation for future expansions.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 18 $87.87entry
- T+1 · 5mo ago −2.38%α −2.06% · $85.78
- T+5 · 5mo ago −7.64%α −5.97% · $81.16
- T+20 · 4mo ago −8.15%α −8.68% · $80.71
- T+60 · 2mo ago −3.56%α −5.46% · $84.74
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BHP disclosed a $2.0 billion cost overrun on its Jansen Stage 2 potash project (investment estimate increased from $4.9B to $6.9B) and expects to recognize a ~$2.3B impairment charge on the Jansen asset base ahead of its FY2026 results. The project remains 16% complete with first production now guided to late FY2031. Group FY2027 capex guidance is maintained at ~$11B.
Key Facts
- Jansen Stage 2 total investment estimate increased from US$4.9B to US$6.9B (including contingencies)
- First production for Jansen Stage 2 delayed to late FY2031 (previously late FY2029 per 2023 approval)
- BHP expects to recognize an impairment charge of approximately US$2.3B (before and after tax) on the Jansen project
- Jansen Stage 2 is 16% complete with engineering at 83% complete as of end-May 2026
- Combined Jansen output expected to be 8.5Mtpa, delivering ~10% of global potash production
- Jansen Stage 2 updated IRR of 11% and payback period of 8 years at consensus prices
- Underlying EBITDA margins for Jansen Stage 2 remain above 65%
- BHP Group FY2027 capex guidance remains at approximately US$11B
- Jansen Stage 1 first production on track for mid-CY2027
Financial Impact
~$2.3B impairment charge on Jansen asset base; $2.0B cost overrun on Stage 2 (from $4.9B to $6.9B)
Risk Factors
- Further cost escalation or schedule slippage on Jansen Stage 2 before late FY2031 first production
- Potash price weakness below consensus assumptions could further reduce project returns
- Execution risk on Jansen Stage 1 (mid-CY2027 first production) remains
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-275167 |
| Document: 0001193125-26-275167-index-headers.html | 0001193125-26-275167 |
| Document: 0001193125-26-275167-index.html | 0001193125-26-275167 |
| Document: 0001193125-26-275167.txt | 0001193125-26-275167 |
Track record
15 reports on BHP
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $80.51 Now $79.49 −1.27% settles Feb 10
- Nov 12, 20264d ago 6-K Neutral 2/10 Entry $80.51 Now $79.49 −1.27% settles Feb 10
- Nov 10, 20266d ago Institutional Cluster Neutral 3/10 Entry $81.12 Now $79.49 −2.01% settles Feb 8
- Oct 22, 202625d ago 6-K Neutral 2/10 Entry $77.58 Now $79.49 +2.46% settles Jan 20
- Oct 22, 202625d ago 6-K Neutral 3/10 Entry $77.58 Now $79.49 +2.46% settles Jan 20
- Oct 20, 202627d ago 6-K Neutral 4/10 Entry $80.82 Now $79.49 −1.65% settles Jan 19
- Sep 16, 20268w ago 6-K Neutral 2/10 Entry $84.14 Now $79.49 −5.53% settles Dec 10
- Sep 15, 20268w ago 6-K Neutral 3/10 Entry $84.77 Now $79.49 −6.23% settles Dec 9
- Sep 14, 20269w ago 6-K Neutral 2/10 Entry $84.74 Now $79.49 −6.20% settles Dec 8
- Aug 28, 202611w ago 6-K Neutral 2/10 Entry $95.15 Now $79.49 −16.46% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers